Latest Dana-Farber Cancer Institute Stories
Salk Institute and Dana Farber Cancer Institute researchers contribute to production of largest-ever map of plant protein interactions.
BOSTON, July 21, 2011 /PRNewswire/ -- Zipcar, Inc. (Nasdaq: ZIP), the world's leading car-sharing network, is taking on the 32nd annual Pan-Massachusetts Challenge (PMC) with a team of 25 riders and a goal of raising $150,000 to support cancer research and treatment.
Promising results of PI3K inhibitor study discussed at ASCO annual meeting SCOTTSDALE, Ariz., July 20, 2011 /PRNewswire-USNewswire/ -- A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G.
Cancer biologists at MIT have identified a new lung cancer gene that drives the spread of the deadly condition.
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal.
Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women.
Mixed lineage leukemias rely on epigenetic changes to grow and survive; new molecule shows promise for targeting these changes therapeutically BOSTON, July 11, 2011 /PRNewswire-USNewswire/ -- A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA - so-called epigenetic changes - to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute.
WHITE PLAINS, N.Y., July 11, 2011 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is taking an aggressive and proactive approach to tackling the challenge of improving outcomes for cancer patients with particularly urgent needs.
Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.
BRAINTREE, Mass., June 15, 2011 /PRNewswire/ -- Herman Lowe, who has been battling terminal brain cancer, Glioblastoma, for over two years, has written a free online book, "Brain Cancer: Beating the Odds" about his journey and what he has done to try to help others with this deadly disease.
- An armed gangster.